Vandetanib also demonstrated a direct connection between the outcomes of molecular mechanics and the prognosis of particular proteins in pancreatic tumors when multiomics, molecular dynamics, and system biology analyses of KRAS and TP53 mutations in PDAC were conducted. The gene discussed is KRAS; the disease is pancreatic neoplasm.